| TRANSEO XENOPORT INC.
1708938 24 Dec 2014 | on 08 Nov 2016 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment, alleviation and prevention of cardiovascular diseases and disorders; urological diseases and disorders; urogenital diseases and disorders; gastrointestinal diseases and disorders; gastroesophageal diseases and disorders; migraines including acute migraines and migraine prophylaxis; pain; hypertension; respiratory diseases and disorders; ophthalmic diseases and disorders; cognitive impairment disorders; allergies; diabetes; obesity and excess weight; stroke; cough; emesis; nausea and vomiting; tinnitus; bleeding; erectile and sexual dysfunction; sleep disorders; hot flashes; tremors; spasticity and symptoms of spasticity; hemolytic diseases and disorders; cancer; alcohol, food, nicotine and narcotic addiction and abuse; epilepsy; restless leg syndrome; depression; anxiety; social phobia; bipolar disorder; vulvodynia; amyotrophic lateral sclerosis; Parkinson's disease; attention deficit disorder; schizophrenia; manic depression; cognitive impairment disorders; periodic limb movement disorders; tardive dyskinesia; Huntington's disease; Tourette's syndrome; addictive disorders; congestive heart failure; mood disorders; neurodegenetive disorders; Friedrich's disease; Alzheimer's disease; multiple sclerosis; Pick's disease; skin diseases and disorders; tumor metastasis; psychotic disorders; anxiety disorders; and somatoforms disorders | | | TRANSEO XENOPORT INC.
1353326 26 Jun 2007 | on 14 Jan 2015 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment, alleviation and prevention of cardiovascular diseases and disorders; urological diseases and disorders; urogenital diseases and disorders; gastrointestinal diseases and disorders; gastroesophageal diseases and disorders; migraines including acute migraines and migraine prophylaxis; pain; hypertension; respiratory diseases and disorders; ophthalmic diseases and disorders; cognitive impairment disorders; allergies; diabetes; obesity and excess weight; stroke; cough; emesis; nausea and vomiting; tinnitus; bleeding; erectile and sexual dysfunction; sleep disorders; hot flashes; tremors; spasticity and symptoms of spasticity; hemolytic diseases and disorders; cancer; alcohol, food, nicotine and narcotic addiction and abuse; epilepsy; restless leg syndrome; depression; anxiety; social phobia; bipolar disorder; vulvodynia; amyotrophic lateral sclerosis; Parkinsons disease; attention deficit disorder; schizophrenia; manic depression; cognitive impairment disorders; periodic limb movement disorders; tardive dyskinesia; Huntingtons disease; Tourettes syndrome; addictive disorders; congestive heart failure; mood disorders; neurodegenetive disorders; Friedrichs disease; Alzheimers disease; multiple sclerosis; Picks disease; skin diseases and disorders; tumor metastasis; psychotic disorders; anxiety disorders; and somatoforms disorders | | | TRANSEON IMRGLOBAL CORP.
1050817 15 Mar 2000 | on 11 Feb 2002 | Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products Computer software for secure message and document transmission and delivery over a global computer information network. | | 
